Therefore, this evidence suggests that suppression of the TGF-β1 and Stat3 signalling pathways could reduce pulmonary fibrosis by inhibiting fibroblast activation and excessive ECM expression. The gene discussed is TGFB1; the disease is pulmonary fibrosis.